PremiumCompany AnnouncementsNLS Pharmaceutics Amends Merger Agreement with Kadimastem Biotech Alert: Searches spiking for these stocks today Biotech Alert: Searches spiking for these stocks today PremiumCompany AnnouncementsNLS Pharmaceutics Reports Positive Results in Fentanyl Study NLS Pharmaceutics’ Mazindol reduces fentanyl-induced reward in animal models NLS Pharmaceutics Secures $3 Million Financing and $25 Million Equity Facility PremiumThe FlyNLS Pharmaceutics and Kadimastem complete pre-IND diabetes meeting with FDA NLS Pharmaceutics and Partners Achieve Milestone in Diabetes Treatment Development Biotech Alert: Searches spiking for these stocks today